334970 — Prestige Biologics Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Prestige Biologics Co, fiscal year end - June 30th, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 June 30th	2024 June 30th
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	4,242	36,775	15,383	45,435	29,507
Net Total Accounts Receivable
Net Total Receivables	408	8,252	2,077	2,073	1,654
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	7,891	54,860	29,835	70,242	55,636
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	40,934	149,989	227,107	234,435	233,052
Net Intangible Assets
Other Long Term Assets
Total Assets	50,233	206,768	258,079	305,753	289,414
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	45,099	28,393	32,552	89,098	92,306
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	51,630	99,936	140,468	205,950	217,732
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	-1,397	106,832	117,611	99,803	71,682
Total Liabilities & Shareholders' Equity	50,233	206,768	258,079	305,753	289,414
Total Common Shares Outstanding